General Session 2: Epidemiology, Diagnosis and Staging

Chairs: Jorge Marrero, MD (USA), Peter Schirmacher, MD (Germany)

  • O-007 Machine Learning Algorithms Outperform Conventional Regression Models in Predicting Development of Hepatocellular Carcinoma
    A. Singal, A. Mukherjee, P. Higgins, A. Lok, J. Zhu, J. Marrero, A. K. Waljee

  • O-008 Hepatocellular Carcinoma Surveillance: An Inquiry into Current Practices
    K. Joshi , B. Ang, R. Gish, R. Loomba, A. Kuo, H. Patton, Y. Kono

  • O-009 Differential Diagnosis of Small Hepatic Nodules by Gd-Eob-Dtpa-Enhanced Mri and Contrast Enhanced Ultrasonography with Sonazoid: Distinction Between Small Progressed HCC and Early HCC
    K. Tsuchiya, Y. Yasui, S. Matsuda, M. Muraoka, N. Tamaki, S. Suzuki, T. Hosokawa, K. Ueda, H. Nakanishi, J. Itakura, M. Kurosaki, N. Izumi

  • O-010 Sub-Classification of Hepatocellular Carcinoma with Barcelona Clinic Liver Cancer Intermediate and Advanced Stage; A Cohort Study Based Upon Korean Multi-Center Registry Database
    B. K. Kim, D. Y. Kim, J. Seong, K. Song, S. Lee, M. N. Kim, K.-H. Han

  • O-011 Regional Differences in Treatment History, Practices, and Outcomes: Final Analysis of Gideon (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib)
    M. Kudo, R. Lencioni, S.-L. Ye, J.-P. Bronowicki, X.-P. Chen, L. Dagher, J. Furuse, J. F. Geschwind, L. Ladrón de Guevara, C. Papandreou, A. J. Sanyal, T. Takayama, S. K. Yoon, A. P. Venook, K. Nakajima, J. Marrero

  • O-012 Dynamic of Pre-Transplant Alpha Fetoprotein Rise Predicts Post-Transplant HCC Recurrence
    D. D. Houlihan, I. A. Rowe, V. Mihaylov, S. Shetty, A. Stangou, R. Doolin, M. J. Armstrong, S.Bramhall, J. Isaac, T. Perera, P. Muiesan, D. Mirza, T. Shah, H. Mergental